Tyers Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Tyers Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$94K	Hold	1,296	–	–	﹤0.01%	856
2019 Q2	$107K	Hold	1,296	–	–	﹤0.01%	839
2019 Q1	$91K	Hold	1,296	–	–	﹤0.01%	853
2018 Q4	$58K	Hold	1,296	–	–	﹤0.01%	868
2018 Q3	$73K	Buy	1,296 +272	+27%	+$16.6K	﹤0.01%	914
2018 Q2	$68K	Hold	1,024	–	–	﹤0.01%	898
2018 Q1	$60K	Hold	1,024	–	–	﹤0.01%	916
2017 Q4	$66K	Buy	1,024 +144	+16%	+$8.96K	﹤0.01%	920
2017 Q3	$46K	Buy	880 +144	+20%	+$6.87K	﹤0.01%	930
2017 Q2	$34K	Buy	736 +416	+130%	+$20.1K	﹤0.01%	942
2017 Q1	$16K	Buy	+320	New	+$18K	﹤0.01%	955

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Tyers Asset Management's ANIP Position: Q3 2019 in Review

Tyers Asset Management held its ANI Pharmaceuticals (ANIP) position steady in Q3 2019 at 1,296 shares worth $94K. The position accounts for ﹤0.01% of the portfolio, ranked #856.

Tyers Asset Management first reported a position in ANIP in Q1 2017 and has held it in 11 quarters since. The position peaked at $107K in Q2 2019. 190 funds tracked by Wall St. Rank hold ANIP as of Q3 2019.

Tyers Asset Management held 1,296 shares of ANI Pharmaceuticals worth $94K as of Q3 2019.
Tyers Asset Management left its ANI Pharmaceuticals share count unchanged in Q3 2019.
ANI Pharmaceuticals made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #856 holding.
Tyers Asset Management first reported a position in ANI Pharmaceuticals in Q1 2017 and has held it in 11 quarters since.
Tyers Asset Management's ANI Pharmaceuticals position peaked at $107K in Q2 2019.
190 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.